FDA approves Biogen and Alkermes' multiple sclerosis drug
FDA approves Biogen and Alkermes' multiple sclerosis drug
Reuters: Health
The U.S. Food and Drug Administration approved Biogen Inc and partner Alkermes Plc's oral drug to treat multiple sclerosis, the companies said on Wednesday.
Reuters: Health
The U.S. Food and Drug Administration approved Biogen Inc and partner Alkermes Plc's oral drug to treat multiple sclerosis, the companies said on Wednesday.
Comments
Post a Comment